CDC: 2012-2013 flu vaccine not as effective in elderly

CDC: 2012-2013 flu vaccine not as effective in elderly
Vaccination against influenza for the 2012/2013 flu season appears to be moderately effective in reducing the need for outpatient medical attention, but the effect is lower in the elderly, according to research published in the Feb. 22 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.

(HealthDay)—Vaccination against influenza for the 2012/2013 flu season appears to be moderately effective in reducing the need for outpatient medical attention, but the effect is lower in the elderly, according to research published in the Feb. 22 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.

Lisa Jackson, M.D., of the CDC in Atlanta, and colleagues analyzed data from the U.S. Influenza Vaccine Effectiveness Network to estimate vaccine effectiveness (VE) for the 2012/2013 influenza season.

The researchers estimated the overall VE against influenza A and B to be 47 and 67 percent, respectively, or 56 percent overall, which was close to the interim estimate of 62 percent. When stratified by age group, the estimates for VE against influenza A (H3N2) and B infections were mostly consistent across age groups, with the exception that lower VE against influenza A (H3N2) was seen among adults aged 65 and older. These findings suggest vaccination against influenza reduces the risk of illness requiring outpatient medical visits by one-half to two-thirds for most people, although VE was lower and not statistically significant among people aged 65 and older.

"Antiviral medications should be used as recommended for treatment of suspected influenza in certain patients, including those aged ≥65 years, regardless of their influenza vaccination status," the authors write.

More information: Full Text

add to favorites email to friend print save as pdf

Related Stories

CDC: Influenza activity increasing across the U.S.

Jan 05, 2013

(HealthDay)—Flu season descended on the United States early and hard this winter, with significant increases in flu activity observed over the past month, according to an update issued Jan. 4 by the U.S. ...

Recommended for you

Drug research and development more efficient than expected

Feb 27, 2015

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

Use new meningitis vaccines only for outbreaks

Feb 26, 2015

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

Feb 26, 2015

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

Tagging drugs to fight counterfeit medicines

Feb 25, 2015

The U.S. and other countries are enacting rules to clamp down on the sales of fake pharmaceuticals, which pose a public health threat. But figuring out a system to track and authenticate legitimate drugs still faces significant ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.